ReconfigBehSci. (2021, May 7). RT @kallmemeg: The @PHE_uk Variant Technical Briefing 10 now published Confirms B.1.617.2 upgraded to a VOC due to transmissibility conce… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1391209724285050883

ReconfigBehSci on Twitter: ‘RT @MOUGK: @AineToole and @viralverity built this incredible tool to visualise, integrate and track VOCs https://t.co/MRPJqdAkJ9 more updat…’ / Twitter. (n.d.). Retrieved 16 August 2021, from https://twitter.com/SciBeh/status/1395144412741603329

Lyngse, F. P., Mortensen, L. H., Denwood, M. J., Christiansen, L. E., Møller, C. H., Skov, R. L., Spiess, K., Fomsgaard, A., Lassaunière, M. M., Rasmussen, M., Stegger, M., Nielsen, C., Sieber, R. N., Cohen, A. S., Møller, F. T., Overvad, M., Mølbak, K., Krause, T. G., & Kirkeby, C. T. (2021). SARS-CoV-2 Omicron VOC Transmission in Danish Households (p. 2021.12.27.21268278). medRxiv. https://doi.org/10.1101/2021.12.27.21268278

Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005

Wong, S.-C., Au, A. K.-W., Chen, H., Yuen, L. L.-H., Li, X., Lung, D. C., Chu, A. W.-H., Ip, J. D., Chan, W.-M., Tsoi, H.-W., To, K. K.-W., Yuen, K.-Y., & Cheng, V. C.-C. (2022). Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: A challenge of elimination strategy of COVID-19. The Lancet Regional Health – Western Pacific, 18. https://doi.org/10.1016/j.lanwpc.2021.100360

“Endemic” Covid? The pandemic will only be over when the world is jabbed. (2022, January 15). Inews.Co.Uk. https://inews.co.uk/news/politics/endemic-covid-the-pandemic-will-only-be-over-when-the-world-is-jabbed-1402691

Hirose, R., Itoh, Y., Ikegaya, H., Miyazaki, H., Watanabe, N., Yoshida, T., Bandou, R., Daidoji, T., & Nakaya, T. (2022). Differences in environmental stability among SARS-CoV-2 variants of concern: Omicron has higher stability [Preprint]. Microbiology. https://doi.org/10.1101/2022.01.18.476607

Mrigank Shail, MD. (2022, January 11). Update on Omicron by Dr @mvankerkhove from @WHO’s Q&A https://t.co/NqCOvs59Tl [Tweet]. @mrigankshail. https://twitter.com/mrigankshail/status/1481006646826577925

Kirby, J. (2021, December 23). Omicron collides with a struggling global vaccination campaign. Vox. https://www.vox.com/22846774/omicron-global-vaccines-covronavirus-covid-19

HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung. (n.d.). Retrieved January 16, 2022, from https://www.med.hku.hk/en/news/press/20211215-omicron-sars-cov-2-infection?utm_medium=social&utm_source=twitter&utm_campaign=press_release

CNN, B. M. H. (n.d.). Holiday travel heats up as the Omicron situation unfolds. CNN. Retrieved January 16, 2022, from https://www.cnn.com/travel/article/holiday-travel-omicron-2021/index.html

Harry Spoelstra. (2021, November 26). Breaking: ECDC has designated B.1.1.529 today as a #VOC https://t.co/WyLnc9xUoJ [Tweet]. @HarrySpoelstra. https://twitter.com/HarrySpoelstra/status/1464261361370910721

World Health Organization (WHO). (2021, December 2). Dr @mvankerkhove updates on what we know so far about the new #COVID19 variant of concern, Omicron ⬇️ https://t.co/43jqMUotrX [Tweet]. @WHO. https://twitter.com/WHO/status/1466376465990180864

Wilhelm, A., Widera, M., Grikscheit, K., Toptan, T., Schenk, B., Pallas, C., Metzler, M., Kohmer, N., Hoehl, S., Helfritz, F. A., Wolf, T., Goetsch, U., & Ciesek, S. (2021). Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies (p. 2021.12.07.21267432). https://doi.org/10.1101/2021.12.07.21267432

Altmann, D. M., & Boyton, R. J. (2021). SARS-Cov-2 immune waning and reinfection in care-home settings. The Lancet. Healthy Longevity, 2(12), e776–e777. https://doi.org/10.1016/S2666-7568(21)00276-2

Boffey, D. (2021, December 15). Omicron likely to accelerate death toll in Europe, says health agency. The Guardian. https://www.theguardian.com/world/2021/dec/15/omicron-covid-likely-accelerate-death-rate-europe-eu-health-agency

Roessler, A., Riepler, L., Bante, D., Laer, D. von, & Kimpel, J. (2021). SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals (p. 2021.12.08.21267491). https://doi.org/10.1101/2021.12.08.21267491

What do we know about the new B.1.1.529 coronavirus variant and should we be worried? (n.d.). Retrieved 10 December 2021, from https://www.gavi.org/vaccineswork/what-we-know-about-new-b11529-coronavirus-variant-so-far

Cotterill, J. (2021, November 26). South African anger over ‘rushed’ Covid travel restrictions. Financial Times. https://www.ft.com/content/6a177732-4faf-4ecb-adc1-667c22248e0f

News, B. N. O. (2021, November 26). Tracking COVID-19 variant Omicron. BNO News. https://bnonews.com/index.php/2021/11/omicron-tracker/

N, P, & R. (2021, November 27). Does omicron pose a risk to the vaccinated? Too early to tell, epidemiologist says. NPR. https://www.npr.org/2021/11/27/1059539509/too-early-to-tell-whether-omicron-poses-a-threat-to-vaccinated-epidemiologist-sa

Reuters. (2021, November 29). First suspected case of Omicron variant of COVID-19 detected in Switzerland. Reuters. https://www.reuters.com/markets/europe/first-suspected-case-omicron-variant-covid-19-detected-switzerland-2021-11-29/

Wheatley, A. K., & Juno, J. A. (2021). COVID-19 vaccines in the age of the delta variant. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00688-5

Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Murugesan, D. R., Desiraju, B. K., Kshetrapal, P., Pandey, R., Scaria, V., Malik, P. K., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00680-0

Davis, N. (2021, October 19). Offshoot of Covid Delta variant on the rise in England. The Guardian. https://www.theguardian.com/world/2021/oct/19/fears-grow-in-england-over-rise-of-new-covid-delta-variant

Shapiro, J., Dean, N. E., Madewell, Z. J., Yang, Y., Halloran, M. E., & Longini, I. (2021). Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports [Preprint]. Epidemiology. https://doi.org/10.1101/2021.05.20.21257461

ReconfigBehSci. (2021, June 5). RT @TWenseleers: Estimated growth rate advantage of B.1.617.2 vs B.1.1.7 is 8.3%/day [7.9-8.8%] 95% CLs and 4%/day [3-5%] for B.1.617.1 vs… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1402243029407178757

de Oliveira T, Lutucuta S, Nkengasong J, Morais J, Paixao JP, Neto Z, Afonso P, Miranda J, David K, Ingles L, Amilton P A P R R C, Freitas H R, Mufinda F, Tessema K S , Tegally H, San E J, Wilkinson E, Giandhari J, Pillay S, Giovanetti M, Naidoo Y, Katzourakis A, Ghafari M, Singh L, Tshiabuila D, Martin D, Lessells R. (2021) A Novel Variant of Interest of SARS-CoV-2 with Multiple Spike Mutations Detected through Travel Surveillance in Africa. medRxiv. https://www.krisp.org.za/publications.php?pubid=330. Accessed 26 March 2021.

mixed = positive + negative

= participants, subjects (in an experiment)